Bausch Health Companies (BHC) Cash from Financing Activities (2016 - 2025)
Bausch Health Companies (BHC) has disclosed Cash from Financing Activities for 17 consecutive years, with -$235.0 million as the latest value for Q4 2025.
- Quarterly Cash from Financing Activities fell 376.47% to -$235.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$742.0 million through Dec 2025, up 14.52% year-over-year, with the annual reading at -$742.0 million for FY2025, 14.52% up from the prior year.
- Cash from Financing Activities hit -$235.0 million in Q4 2025 for Bausch Health Companies, up from -$719.0 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $1.8 billion in Q3 2023 to a low of -$1.2 billion in Q3 2021.
- Historically, Cash from Financing Activities has averaged -$106.1 million across 5 years, with a median of -$167.5 million in 2024.
- Biggest five-year swings in Cash from Financing Activities: crashed 888.89% in 2021 and later surged 5144.44% in 2023.
- Year by year, Cash from Financing Activities stood at $275.0 million in 2021, then tumbled by 200.36% to -$276.0 million in 2022, then skyrocketed by 71.38% to -$79.0 million in 2023, then surged by 207.59% to $85.0 million in 2024, then crashed by 376.47% to -$235.0 million in 2025.
- Business Quant data shows Cash from Financing Activities for BHC at -$235.0 million in Q4 2025, -$719.0 million in Q3 2025, and $358.0 million in Q2 2025.